Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Current Liabilities (2020 - 2025)

NeuroPace has reported Total Current Liabilities over the past 6 years, most recently at $17.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $17.8 million for Q4 2025, up 17.54% from a year ago — trailing twelve months through Dec 2025 was $17.8 million (up 17.54% YoY), and the annual figure for FY2025 was $17.8 million, up 17.54%.
  • Total Current Liabilities for Q4 2025 was $17.8 million at NeuroPace, down from $19.6 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for NPCE hit a ceiling of $19.6 million in Q3 2025 and a floor of $7.6 million in Q2 2021.
  • Median Total Current Liabilities over the past 5 years was $12.3 million (2022), compared with a mean of $12.8 million.
  • Biggest five-year swings in Total Current Liabilities: surged 49.82% in 2022 and later decreased 18.1% in 2023.
  • NeuroPace's Total Current Liabilities stood at $9.3 million in 2021, then increased by 18.01% to $11.0 million in 2022, then surged by 47.86% to $16.2 million in 2023, then fell by 6.61% to $15.2 million in 2024, then rose by 17.54% to $17.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $17.8 million (Q4 2025), $19.6 million (Q3 2025), and $17.1 million (Q2 2025) per Business Quant data.